Irccs Ospedale San Raffaele
Clinical trials sponsored by Irccs Ospedale San Raffaele, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Chinatown screening drive aims to uncover silent hepatitis infections Results expected Dec 2026 (estimated)
- New scan could spot hidden tumors in rare genetic disease Results expected Dec 2026 (estimated)
- Diet boosts IBD drug power? new study tests food as medicine Results expected Apr 2027 (estimated)
- Heart ablation study aims to improve arrhythmia treatment Results expected Apr 2027 (estimated)
- New study to map normal thyroid size in italian newborns Results expected May 2027 (estimated)
-
Heart mapping showdown: which technique stops dangerous rhythms best?
Disease control Recruiting nowThis study compares two methods—DEEP mapping and activation mapping—used during catheter ablation to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. About 222 adults with an implanted defibrillator and VT will be randomly assigned to one technique. The goal is…
Sponsor: IRCCS Ospedale San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Heart rhythm showdown: second ablation or drugs after first success?
Disease control Recruiting nowThis study looks at people with an implanted defibrillator who had a successful first procedure to fix a dangerous fast heart rhythm (ventricular tachycardia). A few days later, they get a non-invasive heart stimulation test. If the test triggers the rhythm again, patients are ra…
Sponsor: IRCCS Ospedale San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Diet boosts IBD drug power? new study tests food as medicine
Disease control Recruiting nowThis study tests whether adding a special diet called the Crohn's Disease Exclusion Diet (CDED) to standard anti-TNF therapy can improve outcomes for people with active Crohn's disease or ulcerative colitis. Eighty adults starting anti-TNF drugs will be randomly assigned to eithe…
Sponsor: IRCCS Ospedale San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New scan could spot hidden tumors in rare genetic disease
Diagnosis Recruiting nowThis study tests a special PET scan that uses a radioactive tracer to find tumors in people with Von Hippel-Lindau (VHL) disease, a genetic condition that causes tumors to grow. About 38 adults with VHL will receive one dose of the tracer and then have a PET/CT scan. The goal is …
Phase 2 • Sponsor: IRCCS Ospedale San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC